For emerging biotech firms, obtaining capital can be a critical challenge. Hiring a full-time Chief Financial Executive is often prohibitively costly, especially when profits are constrained. A fractional CFO provides https://murraynfpa766480.blogdigy.com/fractional-cfo-a-biotech-funding-lifeline-65705461